You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Developing Novel Mechanism of Action Antivirals for Bunyavirus Therapeutics

    SBC: CFD RESEARCH CORPORATION            Topic: CBD212006

    This project seeks to develop a new broad-spectrum antiviral drug against viruses from the Bunyavirales family. These viruses have been designated as being among the highest potential to cause the next pandemic. CFD Research is advancing a natural product-derived antiviral chemistry that has demonstrated strong in vitro potency against Bunyaviruses with low cytotoxicity. We seek to produce an opti ...

    SBIR Phase II 2023 Department of DefenseOffice for Chemical and Biological Defense
  2. Portable Cold Plasma System for Biowarfare Agent Decontamination

    SBC: CFD RESEARCH CORPORATION            Topic: CBD203003

    Biowarfare agents pose a significant threat to military personnel and operations and effective decontamination strategies are needed to mitigate risks associated with exposure. Traditional “wet” decontamination techniques utilize harsh chemicals (e.g. bleach) and are unsuitable for sensitive equipment (e.g. communications equipment). Plasmas consisting of ionized gases, radicals and free elect ...

    SBIR Phase II 2022 Department of DefenseOffice for Chemical and Biological Defense
  3. Austere environment, durable, safe, glass equivalent auto injector container technology

    SBC: SIO2 MEDICAL PRODUCTS INC            Topic: CBD202003

    Autoinjectors are a critical piece of medical countermeasure equipment for the general public and our nation’s warfighters. Autoinjectors are used to deliver injectable drugs at home or in the field. Injectable drugs are typically packaged in traditional glass primary containers that are assembled into the auto-injector. Unfortunately, the glass autoinjector containers in use today are at risk o ...

    SBIR Phase II 2022 Department of DefenseOffice for Chemical and Biological Defense
  4. Portable Cold Plasma System for Biowarfare Agent Decontamination

    SBC: CFD RESEARCH CORPORATION            Topic: CBD203003

    Biowarfare agents pose a significant threat to military personnel and operations. Effective decontamination strategies that eliminate the biowarfare agents prior to human exposure can help mitigate risks associated with exposure. Traditional decontamination techniques rely on “wet” solutions such as chemicals including bleach. However, these decontaminants are unsuitable for sensitive equipmen ...

    SBIR Phase I 2021 Department of DefenseOffice for Chemical and Biological Defense
  5. Infectious Disease Diagnostics and Differentiation of Viral vs. Bacterial Infections for Point of Care Applications

    SBC: GENECAPTURE, INC.            Topic: CBD15C001

    GeneCapture, Inc. is developing a novel, portable and rapid direct infection diagnostic with applications for Warfighter health and readiness. This innovative Sample-to-Answer technology can screen a human sample for many pathogens simultaneously and withstand the rigors of shipping to low resource or restricted areas. It is designed to be easy to use by available personnel. The solution is based ...

    SBIR Phase II 2021 Department of DefenseOffice for Chemical and Biological Defense
  6. Austere environment, durable, safe, glass equivalent auto injector container technology

    SBC: SIO2 MEDICAL PRODUCTS INC            Topic: CBD202003

    SiO2 Materials Science (SiO2) is a U.S. advanced medical technology company that produces high-performance, durable, glass-equivalent primary containers that are uniquely designed to store, transport, and protect drugs, including those that require cold-chain storage. SiO2 is an SBA Defense SBIR/STTR Innovation Portal (DSIP) small business. SiO2’s primary containers are wholly manufactured in ...

    SBIR Phase I 2021 Department of DefenseOffice for Chemical and Biological Defense
  7. Self-contained Equipment Decontamination System (SCEDS)

    SBC: Integrated Solutions for Systems, Inc.            Topic: CBD192002

    The processes and systems required to decontaminate personnel have received much attention and several effective systems exist. However, decontamination of sensitive equipment, without damage or performance degradation, is a significantly different problem that has not been adequately solved. The wide variety of electronics, fabrics and structural materials together with the infinite variations in ...

    SBIR Phase I 2020 Department of DefenseOffice for Chemical and Biological Defense
  8. Novel Circulating RNA-based Markers as Diagnostic Biomarkers of Infectious Diseases

    SBC: CFD RESEARCH CORPORATION            Topic: CBD18A001

    In resource limited settings, rapid and accurate diagnosis of infections is critical for managing potential exposures to highly virulent pathogens, whether occurring from an act of bioterrorism or a natural event. This is especially important for hard to detect intracellular bacterial and alphavirus infections, that overlap symptomatically and often treated empirically due to a lack of reliable an ...

    STTR Phase II 2020 Department of DefenseOffice for Chemical and Biological Defense
  9. Novel Circulating RNA-based Markers as Diagnostic Biomarkers of Infectious Diseases

    SBC: CFD RESEARCH CORPORATION            Topic: CBD18A001

    In resource limited settings, rapid and accurate diagnosis of infections is critical for managing potential exposures to highly virulent pathogens,whether occurring from an act of bioterrorism or a natural event. This is especially important for hard to detect intracellular bacterial andalphavirus infections, that overlap symptomatically and often treated empirically due to a lack of reliable and ...

    STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense
  10. Infectious Disease Diagnostics and Differentiation of Viral vs. Bacterial Infections for Point ofCare Applications

    SBC: GENECAPTURE, INC.            Topic: CBD15C001

    GeneCapture, Inc. is proposing to develop a rapid in vitro diagnostic prototype using our patented molecular-based CAPTURE (ConfirmActive Pathogens Through Unamplified RNA Expression) assay. Based on the results and experience gained in our Phase I STTR contractHDTRA1-16C-0061: Infectious Disease Diagnostics and Differentiation of Viral vs. Bacterial Infections for Point of Care Applications, we p ...

    STTR Phase II 2018 Department of DefenseOffice for Chemical and Biological Defense
US Flag An Official Website of the United States Government